BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1032183)

  • 21. Actinic keratoses treated with a combination of topical 5-fluorouracil and dinitrochlorobenzene.
    Price NM
    Dermatologica; 1979; 158(4):279-86. PubMed ID: 428615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cross allergies following sensitization with dinitrochlorbenzol (DNCB)].
    Djawari D; Körner E; Haneke E
    Hautarzt; 1980 Apr; 31(4):198-202. PubMed ID: 7399912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of local non-specific sensitization with 2,4-dinitrochlorbenzene on chemical carcinogenesis].
    Kurtenkov OA; Mirme KhIu
    Vopr Onkol; 1975; 21(6):116-20. PubMed ID: 1210153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Alopecia and immunotherapy using 2,4-dinitrochlorobenzene (author's transl)].
    Prenosil J
    Cesk Dermatol; 1981 Oct; 56(5):307-11. PubMed ID: 7307091
    [No Abstract]   [Full Text] [Related]  

  • 25. Basal cell nevus syndrome. Unresponsiveness of early cutaneous lesions to topical 5-fluorouracil or dinitrochlorobenzene.
    Hazen PG; Taub SJ
    Dermatologica; 1984; 168(6):287-9. PubMed ID: 6745474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effect of dinitrochlorobenzene (DNCB) on verruca plana and verruca vulgaris.
    Lee S; Cho CK; Kim JG; Chun SI
    Int J Dermatol; 1984 Nov; 23(9):624-6. PubMed ID: 6519874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy of verrucae vulgares with dinitrochlorobenzene.
    Buckner D; Price NM
    Br J Dermatol; 1978 Apr; 98(4):451-5. PubMed ID: 638051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunotherapy of tumors: from the laboratory to the clinic].
    Castermans A; Vanwijck R
    Rev Med Liege; 1976 Dec; 31(24):767-8. PubMed ID: 1005982
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of common warts with topically applied DNCB (author's transl)].
    Czarnecki N; Hintner H
    Wien Klin Wochenschr; 1979 Dec; 91(24):822-5. PubMed ID: 547492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical immunotherapy of basal cell carcinomas with dinitrochlorobenzene.
    Levis WR; Kraemer KH; Klingler WG; Peck GL; Terry WD
    Cancer Res; 1973 Nov; 33(11):3036-42. PubMed ID: 4748451
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunotherapy of multiple recurring warts. Reassessment of the use of dinitrochlorobenzene (author's transl)].
    Claudy AL; Roche H; Gogue Y
    Ann Dermatol Venereol; 1980 Jun; 107(6):551-3. PubMed ID: 7425460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical immunotherapy in dermatology.
    Buckley DA; du Vivier AW
    Int J Clin Pract; 1999 Mar; 53(2):130-7. PubMed ID: 10344049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dinitrochlorobenzene immunotherapy for verrucae resistant to standard treatment modalities.
    Dunagin WG; Millikan LE
    J Am Acad Dermatol; 1982 Jan; 6(1):40-5. PubMed ID: 6211471
    [No Abstract]   [Full Text] [Related]  

  • 34. [1-Chloro-2,4-dinitrobenzene ointment for sensitization, testing and therapy of malignant melanoma patients].
    Burg G; Braun-Falco O
    Dtsch Med Wochenschr; 1977 Feb; 102(6):210-1. PubMed ID: 832608
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter: 5-F.U. or D. N.C.B. for non-clinical vaginal cancer.
    Guthrie D; Way S
    Lancet; 1976 Apr; 1(7965):906. PubMed ID: 58167
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of dinitrochlorobenzene in the treatment of vulvar carcinoma in situ.
    Foster DC; Woodruff JD
    Gynecol Oncol; 1981 Jun; 11(3):330-9. PubMed ID: 7250758
    [No Abstract]   [Full Text] [Related]  

  • 37. Dinitrochlorobenzene immunotherapy of recurrent squamous papilloma of the conjunctiva.
    Petrelli R; Cotlier E; Robins S; Stoessel K
    Ophthalmology; 1981 Dec; 88(12):1221-5. PubMed ID: 7322471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical treatment of alopecia areata.
    Swanson NA; Mitchell AJ; Leahy MS; Headington JT; Diaz LA
    Arch Dermatol; 1981 Jul; 117(7):384-7. PubMed ID: 7259216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generalized urticaria from DNCB.
    Valsecchi R; Foiadelli L; Reseghetti A; Cainelli T
    Contact Dermatitis; 1986 Apr; 14(4):254-5. PubMed ID: 2941231
    [No Abstract]   [Full Text] [Related]  

  • 40. [Regression of melanoma metastases after immunological therapy].
    Malek-Mansour S; Castermans-Elias S; Lapière CM
    Dermatologica; 1973; 146(3):156-62. PubMed ID: 4717482
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.